Developing Precision Medicine for Bladder Cancer

Volume: 35, Issue: 3, Pages: 633 - 653
Published: Jun 1, 2021
Abstract
The hallmark of precision medicine involves tailoring the treatment to the patient and/or tumor-specific biomarkers. Candidate biomarkers in bladder cancer are abundant, but few have been validated in clinical practice. Significant obstacles to precision medicine in bladder cancer include the limited predictive value of candidate biomarkers, lack of standardization in biomarker assessment, heterogeneity in biomarker expression and function, and...
Paper Details
Title
Developing Precision Medicine for Bladder Cancer
Published Date
Jun 1, 2021
Volume
35
Issue
3
Pages
633 - 653
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.